September 2026 — page 2
Tamboran Delivers First Beetaloo Gas to Northern Territory
The company contracted 40 TJ/d (gross) of Pilot Project gas to the Northern Territory Government at a fixed, CPI-escalated price as it completed the Sturt Plateau Compression Facility about US$9 million under budget.
Titan International to Sell Italtractor ITM Undercarriage for Up to $285 Million
The off-highway wheel and tire maker said the cash asset sale will sharpen focus on core operations and fund accretive growth and debt reduction.
Fox Factory to Sell Marucci Parent for $225 Million
The suspension maker is exiting the sports-equipment brand after a February review, citing weaker-than-expected returns and a need to strengthen its balance sheet.
Salesforce, Apple, and NVIDIA Spend Cash on Share Repurchases
JPMorgan Chase and Bank of America also reported common-share buyback cash in the same calendar quarter.
GameStop Insiders Buy $26.8 Million of GME Stock
Eleven issuers drew two or more distinct insider open-market buyers in the week ending 2026-09-24.
Apple's Double-Digit Growth Anchors Hardware Demand
Hardware issuers posted a wave of positive demand and outlook comments as Apple, ADTRAN, and others described broad-based strength.
Trial expands with Seiyu acquisition
Trial identifies integration and financial soundness as key management priorities.
Aimechatec revenue rises on semiconductor business growth
Annual orders rose 60.6% to 43,289 million yen.
Monogatari’s Annual Operating Profit Rose 31.4%
Profit attributable to owners of the parent increased 42.0%.
Lasertec orders recovered in fiscal year ended June 2026
Service revenue rose 36.5% to 58,646 million yen.
Shibuya operating profit fell 4.9%
Packaging plant operating profit rose 5.3% from the preceding fiscal year.
Sho-Bond backlog declines as orders fall short of sales
The company expects earthquake-strengthening orders from Nexco East Japan to recover.
TD SYNNEX Growth Accelerates to 37.7% on Record Quarter
Revenue reached $21.6 billion, above the high end of the $18.2 billion to $19.0 billion outlook, as non-GAAP gross billings hit $31.8 billion.
Fuller Raises Fiscal 2026 Ebitda Outlook After Pricing Turn
Organic revenue rose 4.4% in the third quarter as pricing lifted net revenue 7.4%, and the company now sees fiscal 2026 adjusted EBITDA of $655 million to $670 million.
Darden Reaffirms Fiscal 2027 Outlook After Same-Sales Slowdown
Blended same-restaurant sales rose 3.1% on a fiscal calendar basis as total sales reached $3.2 billion, and the company kept full-year diluted earnings of $11.10 to $11.35.
Costco's Fourth-Quarter Sales Growth Eases From Third Quarter
Fourth-quarter net sales rose 11.2% to $93.9 billion, a slower year-over-year pace than the third quarter's 11.6% increase.
BlackBerry Lifts Fiscal 2027 Outlook After Record QNX Quarter
Second-quarter revenue was $163.3 million, up 26% from a year earlier, as QNX posted a record $80.3 million and the company raised its full-year outlook.
Select Water Solutions to Buy Pilot Water for $700 Million
The water-infrastructure operator will fold a private Delaware Basin midstream company into its recycling and disposal network.
Vertiv to Buy King Environmental in EMEA Thermal Deal
The critical-infrastructure provider said the purchase is expected to extend fluid-management services into Europe, Middle East and Africa after a North America-focused PurgeRite close.
Ligand to Invest Up to $47 Million in AvenCell
The royalty aggregator said the stake will help advance AvenCell’s CRISPR-engineered allogeneic CAR-T programs in AML and B-cell malignancies.
Akamai to Take Anthropic $11.6 Billion Cloud Commitment
The cybersecurity and cloud computing company said a seven-year contract will fund Anthropic’s rising CPU workloads on Akamai Cloud’s distributed AI infrastructure.
Archer to Acquire Boeing’s Wisk, SkyGrid and Insitu Units
The eVTOL maker said the deal will fold autonomy, UAS and airspace-intelligence businesses into its ZEE physical-AI platform, with Boeing taking a stake.
Food, Beverage & Tobacco Demand Stays Positive as Outlook Lifts
Demand comments stayed positive and outlook turned constructive even as avocado prices and tequila volumes weighed.
Paychex Raises PEO Growth Outlook After Advisory Mix Shift
PEO and Insurance Solutions revenue rose 12% to $367.6 million as Management Solutions growth cooled to 4%.
General Mills Restores Organic Sales After a Third-Quarter Drop
Organic net sales were essentially flat in the fiscal 2027 first quarter, reversing a 3% organic decline, as reported sales fell 3% to $4.4 billion on the U.S. yogurt sale.
Cintas Raises Fiscal 2027 Outlook After Record Margin
Organic revenue growth reached 8.9% and gross margin hit a record 51.5% of sales in the quarter ended Aug. 31, 2026.
Sprinklr Profit Flips as Asana, Planet Labs Stay Loss-Making
Sprinklr posted GAAP operating and net income in the three months ended April 30, 2026, while Asana and Planet Labs still reported net losses and large accumulated deficits.
Bio-Techne Shareholders Approve Merck KGaA's $11.3 Billion Cash Bid
The life-science tools maker cleared the merger vote as remaining regulatory approvals still stand between the parties and a late-2026 or early-2027 close.
Aermont Completes $1.03 Billion Cash Purchase of Park Holidays
Sun Communities closed the sale of its UK holiday-park business, leaving it a pure-play North American MH and RV owner and operator.
Royal Caribbean to Form $3 Billion Sandals Joint Venture
The cruise operator said the partnership expands it into an adjacent vacation category and accelerates growth of the all-inclusive brands.
Ondas to Buy Three Defense Firms in $56 Million Mixed Deal
The autonomous-systems company said the three purchases will add technologies for autonomous platforms in contested environments.
ONE Nuclear Energy to Go Public via Hennessy VII Combination
The SPAC deal would list the gas-and-SMR developer on Nasdaq as ONEN after a first-half 2026 close.
FMC to Buy Tessenderlo Group in $403 Million Cash Deal
The agricultural sciences company will pay $13.30 a share after a minority stake from Tessenderlo earlier this year.
Accelerant Go-Shop Ends With No Rival Bids
The specialty-insurance platform's 40-day shop produced no alternative offers as the Thoma Bravo take-private remains slated for the first half of 2027.
Apogee Enterprises Completes GroGlass Acquisition
The building-products company closed its purchase of the Riga-based coatings maker to add anti-reflective technology to Performance Surfaces.
Worthington Organic Growth Rebounds After a Slow Close
Organic sales growth accelerated to 7% in the fiscal 2027 first quarter as net sales reached $343.9 million.
Thor Withholds Fiscal 2027 Guidance After Profit Collapse
Fourth-quarter net income attributable to THOR was $40.8 million, or $0.78 a share, as the company deferred fiscal 2027 guidance pending Hershey and Elkhart industry events.
KB Home Backlog Rises After Four-Year Stagnation
The homebuilder posted $1.30 billion of third-quarter revenue and $1.05 a share as deliveries, price and margins recovered sequentially.
AutoZone Reverses Gross-Margin Decline on Tariff Refunds
Fourth-quarter net sales were $6.6 billion, up 5.6%, as gross profit as a percentage of sales reached 53.3%.
Talos Energy Closes $420 Million Gulf of America Asset Purchase
The offshore E&P said the Shell deepwater closing advances its plan to build a long-lived, scaled portfolio.
Progress Software to Buy Domo Platform in $400 Million Cash Deal
The AI infrastructure software company will fold Domo’s cloud-native data platform into its existing offerings and keep the seller as a listed shell with net cash and NOLs.
Ligand to Buy Santen's Ryjunea for $23 Million
The biopharma royalty aggregator is adding the first approved pharmacological treatment for slowing pediatric myopia in the EU and UK to its expanding royalty book.
Cognex to Buy RealSense in $500 Million Cash Deal
The machine-vision company said the purchase is a move into robotic perception as it diversifies its growth engine.
New Pacific Metals Net Loss Widens to $4.19 Million
The mining issuer ended its fiscal year with $38.57 million in cash and cash equivalents
Brookfield Corporation guarantees US$600 million note offering
The company provided a full guarantee for notes priced at 99.966% of their principal amount.
Viking’s GLP-1/GIP agonist advances through Phase 3 development
VK2735’s pivotal injection trials are fully enrolled, while early maintenance findings explore less frequent dosing and an oral Phase 3 start remains planned.
AbbVie’s Rinvoq offers oral treatment for a defined colitis population
The JAK inhibitor’s US label specifies prior TNF-blocker failure or intolerance, and boxed warnings remain central to its use.
Abivax, Merck and Teva–Sanofi pursue the next wave of colitis therapies
Seven selected compounds place investigational programs alongside approved treatments, with trial design and patient setting shaping every comparison.
Merck’s tulisokibart meets a Phase 3 ulcerative-colitis endpoint
The sponsor’s induction readout advances the TL1A program, with detailed results and separate maintenance evidence still important.
Lilly’s Zepbound sets an approved benchmark for dual-agonist obesity drugs
Tirzepatide’s weight-management history helps frame newer candidates, though shared mechanisms do not establish equal efficacy or safety.